M&A Analysis: January, Crisp Start To The Year
Executive Summary
2018 kicked off with 17 medtech M&A deals in January, an increase from the 12 transactions recorded in the same period last year. The month also saw major medtech players reel in some significant acquisitions.
You may also be interested in...
Varian To Pay $1.3bn For Interventional Oncology Specialist Sirtex
Radiation oncology firm Varian believes Sirtex will allow it to expand into additional areas of cancer treatment.
Qiagen Buys STAT-Dx To Launch Next-Gen Syndromic Testing System
Qiagen has agreed to acquire STAT-Dx, a start-up that developed a multiplex diagnostic for common syndromes, for about $147m in upfront cash, and up to $44m in regulatory and commercial milestones.
Boston Scientific Hooks In Millipede, But Still Trailing Behind In Mitral Valve Race
Boston Scientific is pumping money into the high-potential mitral valve repair space by making a strategic investment in Millipede, as well as signing an acquisition option agreement that could be worth nearly half a billion dollars. However, its cardiovascular rivals are already some distance ahead in this space.